GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Scaled Net Operating Assets

ANG Lifesciences India (BOM:540694) Scaled Net Operating Assets : 0.00 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ANG Lifesciences India's operating assets for the quarter that ended in Dec. 2024 was ₹0 Mil. ANG Lifesciences India's operating liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil. ANG Lifesciences India's Total Assets for the quarter that ended in Sep. 2024 was ₹2,423 Mil. Therefore, ANG Lifesciences India's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.00.


ANG Lifesciences India Scaled Net Operating Assets Historical Data

The historical data trend for ANG Lifesciences India's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Scaled Net Operating Assets Chart

ANG Lifesciences India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.90 1.07 0.52 0.52

ANG Lifesciences India Quarterly Data
Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ANG Lifesciences India's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's Scaled Net Operating Assets falls into.



ANG Lifesciences India Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ANG Lifesciences India's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(2367.018-933.231)/2776.617
=0.52

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2424.37 - 57.352
=2367.018

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1661.596 - 167.225 - 561.14
=933.231

ANG Lifesciences India's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(0-0)/2422.948
=0.00

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0 - 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. The Group has two reportable segments: Pharmaceuticals which include Manufacturing of pharmaceutical products, and Packaging and printing which include Prinitng and packaging. Key revenue is generated from Pharmaceuticals.

ANG Lifesciences India Headlines

No Headlines